FOR IMMEDIATE RELEASE
Contact: Scott Kesselman
Director of Communications & Marketing
scott.kesselman@nhia.org
703-993-0081
Association event brings together infusion professionals dedicated to meeting the healthcare needs of the future
Alexandria, Va. (October 25, 2022) — Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C.
The NHIA Annual Conference is the premier education and networking event for the home and alternate site infusion industry. NHIA 2023 will feature four days of educational content on topics selected for their relevance by industry-leading experts. The unparalleled NHIA Expo offers eight dedicated hours to explore the latest products and services that will improve business operations and take quality patient care to the next level.
Home and alternate site infusion clinicians including physicians, pharmacists, nurses, and dieticians work together to manage care—driving clinical outcomes in the home infusion model to be as good or better than those achieved in institutional settings,1 making the home infusion industry perfectly poised to meet the health care needs of the future. The NHIA Annual Conference is the ideal event for infusion professionals or those seeking opportunities in the industry to come together, earn CE or CME, and explore the latest trends in offering home-based services.
“NHIA is excited about opening registration for the 2023 conference and building on the momentum and energy of last year’s event, where we saw record attendance,” said NHIA’s President & CEO Connie Sullivan, BSPharm. “I am particularly thrilled about some of the new events and programs we have planned that will make this conference our best yet, including a DEIA General Session and Keynote, preconference seminar on reimbursement, and Innovation Award for product or service excellence.”
NHIA will continue to offer over to 40 CE for pharmacists, pharmacy technicians, nurses and dietitians as well as add a new offering of over 20 CME for physicians, physician assistants, and nurse practitioners across clinical, nursing and leadership tracks as well as clinical-focused symposia.
The popular NHIA Sterile Compounding Clinic will incorporate changes from the new USP Chapters into the curriculum and provides a rare opportunity for optional hands-on training in a simulated clean room environment. The program offers an additional 15 hours of continuing education credit and is a PTCB-recognized education/training program for the Compounded Sterile Preparation Technician (CSPT) Certification.
Companies can learn more about exhibiting at or attending NHIA’s 2023 Annual Conference, by visiting conference.nhia.org. Exhibitors will have access to over 1,400 infusion professionals with significant purchasing power for supplies, products and services as well as all conference sessions and networking events.
To inquire about media trade opportunities or press registration, please contact NHIA Director of Marketing and Communications, Scott Kesselman, at scott.kesselman@nhia.org.
1 Home Infusion: Safe, clinically effective, patient preferred, and cost saving.
###
National Home Infusion Association (NHIA) is the leading organization providing education, information, advocacy, and resources for the nation’s home and specialty infusion provider community and the manufacturers, suppliers, and service companies that support the field.
The National Home Infusion Association has announced the finalists for its 2024 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
The National Home Infusion Association (NHIA) and Managed Health Care Associates, Inc. (MHA) are pleased to announce the addition of MHA to NHIA’s Future of Infusion Advisory Council (FIAC).
